{"id":"W4413139122","doi":"10.1182/bloodadvances.2024015599","title":"New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"Legend Biotech; Pharmacyclics; Eurostars; Genentech; National Institutes of Health; Juno Therapeutics; Astellas Pharma; Swedish Orphan Biovitrum; Omeros Corporation; BeiGene; Pfizer; Incyte; bluebird bio; Jazz Pharmaceuticals; National Cancer Institute; Servier; Gilead Sciences; Moffitt Cancer Center; Society for Immunotherapy of Cancer; Cidara Therapeutics; Celgene; Fred Hutchinson Cancer Research Center; Karyopharm Therapeutics; Memorial Sloan-Kettering Cancer Center; Massachusetts General Hospital; Amgen; Bristol-Myers Squibb","keywords":"Medicine; Comorbidity; Internal medicine; Hazard ratio; Lymphoma; Diabetes mellitus; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006979234,0.0003264653,0.0003238749,0.0006062794,0.0002919184,0.0005418063,0.0002690099,0.0002882264,0.001276276],"category_scores_gemma":[0.003232177,0.0001116387,0.0005224663,0.0009015687,0.0001575639,0.0003389337,0.0005711896,0.0006441296,0.0001469348],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004823242,"about_ca_system_score_gemma":0.0004227341,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003037076,"about_ca_topic_score_gemma":0.003987052,"domain_scores_codex":[0.9995234,0.0001326036,0.00007524656,0.00008197942,0.000111955,0.00007476095],"domain_scores_gemma":[0.9974818,0.000428743,0.001302502,0.0001139291,0.0002483474,0.000424627],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001206644,0.00001167153,0.9988289,0.000004175498,0.00003837432,0.00001524842,0.00000477637,0.00007297711,0.00008342462,0.00000781537,0.00006767017,0.0007443094],"study_design_scores_gemma":[0.000009451634,0.00006320635,0.9979962,0.000004957531,0.00005127439,0.0001111196,0.00002399992,0.001518366,0.00007798276,0.00002263663,0.0001171151,0.000003669579],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9986894,0.0003077218,0.0002031044,0.00005639248,0.0000146243,0.000008177391,0.000433906,0.000004578648,0.0002820788],"genre_scores_gemma":[0.9993036,0.00004878872,0.00007731104,0.00001188473,0.00001219068,0.000004873516,0.0004941057,0.000001094753,0.00004623771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003037076,"threshold_uncertainty_score":0.006038785,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01401590502790424,"score_gpt":0.2952427108687055,"score_spread":0.2812268058408013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}